Mirae Asset Global Investments’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Other funds holding SUPN
SIMG
RHJA
Mirae Asset Global Investments's SUPN Position: Q2 2026 in Review
Mirae Asset Global Investments reduced its Supernus Pharmaceuticals (SUPN) stake by 13% in Q2 2026, selling an estimated $19K and leaving 2,596 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #1204.
Mirae Asset Global Investments first reported a position in SUPN in Q2 2022 and has held it in 17 quarters since. The position peaked at $843K in Q1 2024. 131 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.
- Mirae Asset Global Investments held 2,596 shares of Supernus Pharmaceuticals worth $121K as of Q2 2026.
- Mirae Asset Global Investments sold 395 Supernus Pharmaceuticals shares in Q2 2026, an estimated $19K.
- Supernus Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1204 holding.
- Mirae Asset Global Investments first reported a position in Supernus Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
- Mirae Asset Global Investments's Supernus Pharmaceuticals position peaked at $843K in Q1 2024.
- 131 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.
Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.